(Q40008433)

English

Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

16 September 2017

Neutralization of Yersinia pestis-mediated macrophage cytotoxicity by anti-LcrV antibodies and its correlation with protective immunity in a mouse model of bubonic plague (English)

1 reference

Europe PubMed Central

16 September 2017

Yersinia pestis

0 references

0 references

0 references

Ayelet Zauberman

1

object named as

Ayelet Zauberman

1 reference

Europe PubMed Central

16 September 2017

Avigdor Shafferman

7

object named as

Avigdor Shafferman

1 reference

Europe PubMed Central

16 September 2017

3

object named as

Yinon Levy

1 reference

Europe PubMed Central

16 September 2017

5

object named as

Shirley Lazar

1 reference

Europe PubMed Central

16 September 2017

Yehuda Flashner

8

object named as

Yehuda Flashner

1 reference

Europe PubMed Central

16 September 2017

author name string

Sara Cohen

2

1 reference

Europe PubMed Central

16 September 2017

Gideon Halperin

4

1 reference

Europe PubMed Central

16 September 2017

Baruch Velan

6

1 reference

Europe PubMed Central

16 September 2017

Emanuelle Mamroud

9

1 reference

Europe PubMed Central

16 September 2017

language of work or name

0 references

publication date

6 February 2008

1 reference

Europe PubMed Central

16 September 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

16 September 2017

26

1 reference

Europe PubMed Central

16 September 2017

13

1 reference

Europe PubMed Central

16 September 2017

1616-1625

1 reference

Europe PubMed Central

16 September 2017

Yersinia pestis--etiologic agent of plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Yersinia pestis (plague) vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Human immune response to a plague vaccine comprising recombinant F1 and V antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Anti-V antigen antibody protects macrophages from Yersinia pestis -induced cell death and promotes phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Yersinia enterocolitica induces apoptosis in macrophages by a process requiring functional type III secretion and translocation mechanisms and involving YopP, presumably acting as an effector protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Immunogenicity of the rF1+rV vaccine for plague with identification of potential immune correlates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Development of in vitro correlate assays of immunity to infection with Yersinia pestis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Generation of Yersinia pestis attenuated strains by signature-tagged mutagenesis in search of novel vaccine candidates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Bacteriocin-like material produced by Pasteurella pestis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Yersinia outer protein P of Yersinia enterocolitica simultaneously blocks the nuclear factor-kappa B pathway and exploits lipopolysaccharide signaling to trigger apoptosis in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Interleukin-10 and inhibition of innate immunity to Yersiniae: roles of Yops and LcrV (V antigen)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Anti-LcrV antibody inhibits delivery of Yops by Yersinia pestis KIM5 by directly promoting phagocytosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Stat 4 but not Stat 6 mediated immune mechanisms are essential in protection against plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Cell-mediated protection against pulmonary Yersinia pestis infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

Passive immunity to yersiniae mediated by anti-recombinant V antigen and protein A-V antigen fusion peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.01.033

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.01.033

1 reference

Europe PubMed Central

16 September 2017

1 reference

Europe PubMed Central

16 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40008433&oldid=1882333256"